Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

• Status: Unknown status
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Research design: randomized, double-blind, placebo-controlled crossover study to evaluate the putative interference of low-dose aspirin (for 8 weeks) on enalapril antiproteinuric properties in microalbuminuric type 2 diabetes mellitus patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Aspirin; Enalapril; Enalaprilat

Criteria

Inclusion Criteria:

• type 2 diabetes mellitus microalbuminuria

Exclusion Criteria:

• ischemic heart disease peptic disease